Nothing Special   »   [go: up one dir, main page]

DE69214369D1 - Verfahren zur Herstellung von Pyranonen und Pyrandionen - Google Patents

Verfahren zur Herstellung von Pyranonen und Pyrandionen

Info

Publication number
DE69214369D1
DE69214369D1 DE69214369T DE69214369T DE69214369D1 DE 69214369 D1 DE69214369 D1 DE 69214369D1 DE 69214369 T DE69214369 T DE 69214369T DE 69214369 T DE69214369 T DE 69214369T DE 69214369 D1 DE69214369 D1 DE 69214369D1
Authority
DE
Germany
Prior art keywords
chem
hydrogen
formula
substituted
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69214369T
Other languages
English (en)
Other versions
DE69214369T2 (de
Inventor
John Joseph Landi
Keith Marriott Ramig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F HOFFMANN-LA ROCHE and Co AG BASEL CH
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F HOFFMANN-LA ROCHE and Co AG BASEL CH, F Hoffmann La Roche AG filed Critical F HOFFMANN-LA ROCHE and Co AG BASEL CH
Publication of DE69214369D1 publication Critical patent/DE69214369D1/de
Application granted granted Critical
Publication of DE69214369T2 publication Critical patent/DE69214369T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69214369T 1991-07-23 1992-07-09 Verfahren zur Herstellung von Pyranonen und Pyrandionen Expired - Lifetime DE69214369T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73440891A 1991-07-23 1991-07-23
US07/849,908 US5274143A (en) 1991-07-23 1992-03-12 Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione

Publications (2)

Publication Number Publication Date
DE69214369D1 true DE69214369D1 (de) 1996-11-14
DE69214369T2 DE69214369T2 (de) 1997-03-27

Family

ID=27112724

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214369T Expired - Lifetime DE69214369T2 (de) 1991-07-23 1992-07-09 Verfahren zur Herstellung von Pyranonen und Pyrandionen

Country Status (7)

Country Link
US (2) US5274143A (de)
EP (1) EP0524495B1 (de)
JP (1) JP3248760B2 (de)
AT (1) ATE143954T1 (de)
DE (1) DE69214369T2 (de)
DK (1) DK0524495T3 (de)
ES (1) ES2092603T3 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5481008A (en) * 1993-09-13 1996-01-02 Hoffmann-La Roche Inc. Process for the preparation of optically active compounds
US6545165B1 (en) * 2000-02-04 2003-04-08 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
CA2416900C (en) 2000-07-28 2007-07-03 F. Hoffmann-La Roche Ag The use of a combination of a lipase inhibitor and a pharmaceutically acceptable bile acid sequestrant for the prevention and treatment of diseases associated with high plasma cholesterol levels
DK1311260T3 (da) 2000-08-09 2008-06-23 Hoffmann La Roche Lipaseinhibitorer til behandling af dyspepsi
US6900226B2 (en) 2000-09-06 2005-05-31 Hoffman-La Roche Inc. Neuropeptide Y antagonists
EP1328515B1 (de) 2000-10-16 2008-08-06 F. Hoffmann-La Roche AG Indolinderivate und deren verwendung als 5-ht2 rezeptor liganden
GB0030710D0 (en) 2000-12-15 2001-01-31 Hoffmann La Roche Piperazine derivatives
AU2002228007B2 (en) 2000-12-27 2007-06-21 F. Hoffmann-La Roche Ag Indole derivatives and their use as 5-HT2b and 5-HT2c receptor ligands
GB0106177D0 (en) 2001-03-13 2001-05-02 Hoffmann La Roche Piperazine derivatives
DE60225274T2 (de) 2001-05-21 2009-03-26 F. Hoffmann-La Roche Ag Chinolinderivate als liganden für den neuropeptid-y-rezeptor
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6730319B2 (en) 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US6787558B2 (en) 2001-09-28 2004-09-07 Hoffmann-La Roche Inc. Quinoline derivatives
SE0104274D0 (sv) * 2001-12-17 2001-12-17 Astrazeneca Ab Novel process
GB0202015D0 (en) 2002-01-29 2002-03-13 Hoffmann La Roche Piperazine Derivatives
KR100659428B1 (ko) 2002-02-04 2006-12-19 에프. 호프만-라 로슈 아게 Npy 길항제로서의 퀴놀린 유도체
AU2003210305B2 (en) 2002-02-28 2006-07-06 F. Hoffmann-La Roche Ag Thiazole derivatives as NPY receptor antagonists
CA2489251A1 (en) 2002-07-05 2004-01-15 F. Hoffmann-La Roche Ag Quinazoline derivatives
WO2004014884A1 (en) 2002-08-07 2004-02-19 F. Hoffmann-La Roche Ag Thiazole derivatives
RU2296759C2 (ru) 2002-09-12 2007-04-10 Ф.Хоффманн-Ля Рош Аг N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты)
MXPA05005445A (es) 2002-11-25 2005-08-26 Hoffmann La Roche Derivados de indolilo.
KR100875318B1 (ko) * 2002-11-26 2008-12-22 화이자 프로덕츠 인크. Ppar 활성화 인자로 사용하기 위한 페닐 치환된피페리딘 화합물
GB0314967D0 (en) 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
BRPI0413500A (pt) 2003-08-12 2006-10-10 Hoffmann La Roche compostos, processos para a sua preparação, composição farmacêutica que compreende os mesmos, utilização de um composto, métodos para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
CA2533464A1 (en) 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag Thiazole derivatives as npy antagonists
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
JP2008540368A (ja) 2005-05-03 2008-11-20 エフ.ホフマン−ラ ロシュ アーゲー 5−ht2リガンドとしての四環式アザピラジノインドリン
EP1912968A1 (de) * 2005-08-04 2008-04-23 Pfizer Limited Piperidinoylpyrrolidin- und piperidinoylpiperidin-verbindungen
WO2007020213A2 (en) 2005-08-18 2007-02-22 F. Hoffmann-La Roche Ag Thiazolyl piperidine derivatives useful as h3 receptor modulators
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101316838B (zh) 2005-11-30 2013-01-30 霍夫曼-拉罗奇有限公司 用作h3调节剂的1,1-二氧代-硫代吗啉基吲哚基甲酮衍生物
BRPI0619233A2 (pt) 2005-11-30 2011-09-20 Hoffmann La Roche compostos, processo para a sua manufatura, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, uso dos compostos e método para o tratamento ou prevenção de obesidade e de diabetes do tipo ii em um ser humano ou animal
CN101316840B (zh) 2005-11-30 2012-08-08 霍夫曼-拉罗奇有限公司 1,5-取代的吲哚-2-基酰胺衍生物
AU2006324089A1 (en) 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Tricyclic amide derivatives useful for treating obesity
ES2334580T3 (es) 2005-12-15 2010-03-12 F. Hoffmann-La Roche Ag Derivados de pirrolo(2,3-c)piridina.
CN101331131A (zh) 2005-12-16 2008-12-24 霍夫曼-拉罗奇有限公司 用作H3受体调节剂的吡咯并[2,3-b]吡啶衍生物
MEP6808A (xx) * 2006-02-23 2010-02-10 Lundbeck & Co As H Priperidinoilpirodolini agonisti receptora menalokortina tipa 4
US7432255B2 (en) * 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
MX2008014532A (es) 2006-05-30 2008-11-27 Hoffmann La Roche Derivados de piperidinil pirimidinas.
US7514433B2 (en) 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
US20100210633A1 (en) * 2006-10-12 2010-08-19 Epix Delaware, Inc. Carboxamide compounds and their use
MX2009004314A (es) 2006-11-13 2009-05-05 Pfizer Prod Inc Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos.
WO2008062276A2 (en) * 2006-11-20 2008-05-29 Glenmark Pharmaceuticals S.A. Acetylene derivatives as stearoyl coa desaturase inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US20080146559A1 (en) 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
EP2183237A1 (de) * 2007-07-25 2010-05-12 F. Hoffmann-Roche AG Benzofuran- und benzo[b]thiophen-2-carbonsäureamidderivate und deren verwendung als modulatoren des histamin-3-rezeptors
WO2009037542A2 (en) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
KR101076680B1 (ko) * 2007-11-01 2011-10-26 한미홀딩스 주식회사 (6r)-3-헥실-4-히드록시-6-운데실-5,6-다이히드로피란-2-온의 제조방법 및 이에 사용되는 중간체
BRPI0820701A2 (pt) 2007-12-11 2015-06-16 Cytopathfinder Inc Composto de carboxamida e seu uso como agonistas do receptor de quimiocina
KR101280786B1 (ko) * 2008-08-06 2013-07-05 화이자 리미티드 멜라노코르틴 4 작용제로서 다이아제핀 및 다이아조칸 화합물
JP2013528172A (ja) 2010-05-21 2013-07-08 ファイザー・インク 2−フェニルベンゾイルアミド
CA2828343A1 (en) 2011-03-04 2012-09-13 The Scripps Research Institute Edn3-like peptides and uses thereof
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN113574055B (zh) 2019-01-18 2024-07-23 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2542849A (en) * 1948-10-22 1951-02-20 Gen Aniline & Film Corp Diazotypes containing pyronones
US4206222A (en) * 1977-06-23 1980-06-03 Societe Civile Particuliere De Brevets Suffren Method for preparing a substance having properties against collagen diseases and products obtained
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones

Also Published As

Publication number Publication date
DE69214369T2 (de) 1997-03-27
DK0524495T3 (da) 1996-11-25
US5420305A (en) 1995-05-30
ES2092603T3 (es) 1996-12-01
US5274143A (en) 1993-12-28
JPH05194471A (ja) 1993-08-03
JP3248760B2 (ja) 2002-01-21
EP0524495A1 (de) 1993-01-27
ATE143954T1 (de) 1996-10-15
EP0524495B1 (de) 1996-10-09

Similar Documents

Publication Publication Date Title
DE69214369D1 (de) Verfahren zur Herstellung von Pyranonen und Pyrandionen
ATE174589T1 (de) Verfahren zur herstellung von piperidinderivaten
HK1004562A1 (en) Stabilized organic material
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
HUT46899A (en) Process for production of new derivatives of 1,4-disubstituted piperasine and medical compositions containing such substances
ATE108323T1 (de) Haarbehandlungszusammensetzung, bleichzusammensetzung und zusammensetzung zur modifizierung des haarfarbtones.
HUT59394A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
DE69026851D1 (de) Verfahren zur Erhöhung von Chemilumineszenz
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
DE68922765D1 (de) Substituierte Naphthalen-Verbindungen und diese enthaltende Flüssigkristall-Zusammensetzungen.
ATE222238T1 (de) Verfahren und zwischenprodukte zur herstellung von piperazinderivaten
HUT57694A (en) Process for producing new beta-diketones and pharmaceutical compositions comprising same
DE60037766D1 (de) Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivate und 3-Aminothiophen Derivate
WO1991000729A3 (en) Bis-dioxopiperazines, and their use as protecting agents
DE3866148D1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
ATE173248T1 (de) Verfahren zur herstellung von metallkomplexen von thiolactamen
DE69800073D1 (de) Verfahren zur Herstellung von 2-Cyanobiphenyl-Verbindungen
BR9104632A (pt) Composto,composicao farmaceutica,aplicacao do referido composto e processo para a preparacao do referido composto
ATE118762T1 (de) Verfahren zur herstellung von 4- methylsulfonylbenzoesäurederivate und zwischenprodukte.
NO914226L (no) Fremgangsmaate og middel til farging av haar
DE69108587D1 (de) Verfahren und Zwischenprodukte zur Herstellung von optisch aktiven Chromanderivaten.
ATE41416T1 (de) 4-aminobutensaeurederivate, herstellungsverfahren und verwendung.
MX165848B (es) Un producto de reaccion, un compuesto y un procedimiento para obtener un compuesto
ATE50569T1 (de) Alpha-allylierte arylalkyltriazole, verfahren zu ihrer herstellung und ihre verwendung als fungizide.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: F. HOFFMANN-LA ROCHE AG, BASEL, CH

8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 524495

Country of ref document: EP